---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-026174"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-03-11T23:59:59+00:00"
generated_at: "2026-05-15T14:53:40.993666+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BiomX stockholders approve share issuance above 19.99% threshold for financing

## Summary
- At special meeting on March 11, 2026, stockholders approved issuance of common shares exceeding 19.99% of outstanding for conversion of Series Y preferred and warrants.
- Proposal 1 received 528,511 votes for, 23,714 against, and 4,753 abstentions.
- Proposal 2 (adjournment) received 524,578 for, 31,778 against, and 622 abstentions; adjournment not needed.
- Record date was Feb 3, 2026; 1,593,516 shares of common stock outstanding and entitled to vote.
- Approval relates to a securities purchase agreement dated Dec 26, 2025 and engagement with H.C. Wainwright & Co.

## SEC filing metadata
- accession: 0001213900-26-026174
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026026174/0001213900-26-026174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026026174/ea028113901-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-026174
- JSON: https://secwatch.observer/filing/0001213900-26-026174.json
- Plain text: https://secwatch.observer/filing/0001213900-26-026174.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.